Are Lloyds shares the pick of the UK banks?

Lloyds shares have more than recovered the minor losses incurred after they announced full year results last week and are shaping up for a run at the 52-week high of 53.97p.

Lloyds was the last FTSE 100 UK bank to report and wrapped an earnings season for the sector which was largely disappointing for those banks with a focus on the UK economy. 

However, when Lloyds is compared to to NatWest and Barclays, there are many positives to take away.

Lloyds share market reaction

First and foremost is the market reaction. Notwithstanding the variations in each respective companies’ metrics, Lloyds shares had the most favourable immediate market reaction to their results.

Both NatWest and Barclays suffered dearly in the aftermath of their full results with NatWest falling nearly 10%. In contrast, the Lloyds share price slipped only 2% and has since more than recovered their initial losses. While this has little bearing on the future performance of the Lloyds share price, it does highlight the market’s favourable perception of Lloyds shares based purely on 2022 results.

UK bank comparisons

UK banking results for 2022 on an underlying basis were very similar. Lloyds, Barclays and NatWest all reported higher net interest margins and an expansion to the top line.

What set the banks apart were impairments charges, one-off litigation costs, and 2023’s outlook.

2022 Net Interest Margin2023 Net Interest Margin Forecast
Lloyds2.94%> 3.05%
Barclays3.54%> 3.20%
NatWest2.85%around 3.20%

Lloyds Net Interest Margin, a key profitability metric, was by no means the highest of the three UK-focused banking giants. However, Lloyds earns the entirety of their income from the UK through retail and business banking.

Barclays has previously enjoyed the benefits of a strong international and markets business, but in 2022 they suffered a litigation costs of £1,597m due to the over issuance of bonds. This hit their earnings and reduced their 2022 profit before tax compared to 2021.

2022 Impairment Charges (£m)Litigation/Remediation
Lloyds1,510255
Barclays1,2201,597
NatWest337385

Lloyds managed to marginally increase profit before tax to £6,928m, despite a £1,510m impairment charge. This would suggest Lloyds has largely priced in the impact of any up coming economic deterioration, and could even reverse the impairments next year.

NatWest recorded an impairment of just £337m and created the uncertainty of additional impairments next year.

2023 Outlook

In terms of the outlook for 2023, all three of the banks suggest Q4 2022 saw a peak in their net interest margins.

The impact of higher interest rates was evident in 2022 banking results. However, a stabilising inflation rate and the threat of an economic downturn means rates are unlikely to increase much further. Certainly not to the extent we saw in 2022.

This will cap banking net interest incomes and make the bank’s increasingly reliant on increased demand for banking products to generate earnings growth.

As the UK’s largest mortgage provider, Lloyds is well placed to benefit from an upside surprise in UK economic conditions. Lloyds does, however, lack the exposure to international financial markets and investment banking that Barclays does. This could mean Barclays outperforms Lloyds in 2023 if capital markets activities enjoy a revival.

Lloyds Dividend Comparison

Lloyds increased their ordinary dividend for the 2022 full year to 2.4p, an increase of 20%. As a result, Lloyds shares have a historical yield of 4.6%, largely in line with their peers.

However, Lloyds willingness to announce an additional £2bn share buyback sets them apart from peers and is likely a core reason for their recent outperformance.

Ordinary 2022 Dividend (p)Historic YieldAdditional Share Buyback (£m)
Lloyds2.4p4.6%2,000
Barclays7.5p4.3%500
NatWest13.5p4.7%800

It must be noted NatWest paid a rewarding 16.8p special dividend in August.

Lloyds Valuation

From a valuation perspective, Lloyds offers very little value compared to their peers. They trade at a premium to the average earnings and NAV multiples. This would imply Lloyds offers little value but also suggests the market feels Lloyds is a higher quality business and deserves a premium valuation.

Forward Price-to-EarningsPrice-to-EarningsPrice-to-NAV
Lloyds6.96.50.7
Barclays5.54.50.4
NatWest6.270.7

Conclusion

Lloyds higher valuation reflects solid underlying earners and a willingness to front-load bad debts, at a time they are prepared to reward investors with higher distributions.

This makes Lloyds a more stable income option.

However, should we see upside surprises to the global economy and a recovery in capital markets, the Lloyds share price may lag their peers.

Tekcapital’s MicroSalt secures additional distribution before IPO

Tekcapital’s MicroSalt is gearing up for their proposed AIM IPO this year with a raft of new agreements for the low-sodium salt shakers.

MicroSalt’s salt technology has reduced overall sodium content in their salt shakers by 50% while still providing the same taste as normal table salt.

Millions of people suffer from cardiovascular disease and the disease has strong links with high sodium intake. Today’s announcement confirms MicroSalt have ensured their products can no help more people improve their diets through a number of new distribution agreements. 

MicroSalt has said their low sodium salt shakers are now available through UNFI and KeHE Foods. UNFI and KeHE are two of the U.S.’s largest retail food distributors and significantly increases the availability of MicroSalt products across the US and Canada.

“Excess sodium intake is one of the world’s greatest health concerns, and partnerships like these are the best way to make a difference in our efforts to address the sodium challenge. We are proud to have our shakers available at both UNFI and KeHe and truly believe that working together we can make a difference.” Said Rick Guiney, CEO of MicroSalt.

The announcement comes as markets prepare for highly anticipated news on MicroSalt’s AIM IPO. MicroSalt said they had appointed Zeus Capital as their AIM Nomad in December and expectations are they will push on with a listing in 2023.

Associated British Foods sales jump but higher costs bite

Associated British Foods (LON:ABF) said sales for the first half rose 20% but warned operating profit would be flat over the full year as higher costs eat into margins.

Primark drove AB Foods higher revenue as sales jumped to £4.2bn, 19% above the same period a year prior at actual exchange rates. AB Foods said they expect Primark’s operating profit to be ahead of prior expectations for the full year as sales increase and costs rise less than expected.

However, rising commodity input prices for the sugar and groceries business are set to scupper any meaningful growth in their foods operating profit. Higher costs in their sugar business due to a poor UK beet crop are to blame for a predicted flat line in profits.

AB Foods shares were 1.4% at the time of writing.

“ABF expects group sales to jump up as consumer spending holds up better than anticipated. Primark’s had a big hand in underpinning the group’s increased sales performance, expecting to see double-digit growth as its customers find refuge from cost-of-living pressures in the value retail store,” said Aarin Chiekrie, equity analyst at Hargreaves Lansdown.

“Despite being well positioned to deal with consumers’ shrinking budgets, ABF is not without its challenges, the main one being significant cost inflation. The group’s trying to offset this through price increases, but this risks alienating the value-chain’s core customer base. This means that cost increases haven’t been fully passed onto customers so far, resulting in Primark’s margins falling from 11.7% to around 8%.”

DX (Group) – Tuffing it out, while revenues and profits delivering very well in current year

In the six months to the end of December 2022 were good for the DX (Group) (LON:DX.).

The company, which is a market leader in the delivery of mail, parcels, pallets and freight of irregular dimension and weight, enjoyed strong trading, some 15% ahead of the previous year.

It reported that customer supply chain issues had normalised, labour market pressures had eased, and costs had been managed effectively.

Accordingly the group’s Management remains confident that the Group is well-positioned to meet its expectations for the financial year despite the economic headwinds, for the second half of the year. 

The Business

First established in 1975 as a Document Exchange service to the legal sector, DX now provides one of the widest ranges of overnight delivery services in the market, as well as courier and logistics services.

DX provides a wide range of specialist delivery services to both business and residential addresses across the UK and Ireland.

The group operates through two divisions, DX Freight and DX Express.

The company’s goal is to deliver exactly to its customers’ requirements, whether via a next day, scheduled or tracked, secure service, and provide assurance through proof of delivery.

Items that DX transports range from confidential documents and valuable packages to large, awkward-to-handle freight, unsuitable for automated conveyor.

The Interim Results

The six months to end December saw the group report a 15% lift in revenues to £231.3m (£202.0m), adjusted pre-tax profits were 96% ahead at £9.2m (£4.7m), earnings per share were 160% better at 1.3p (0.5p), while the group announced a 0.5p (nil) dividend.

CEO Paul Ibbetson stated that:

“The Group performed strongly, with both divisions contributing higher revenue and expanded margins. Trading was helped by the easing of customer supply chain and labour market pressures.

We are also pleased to return to the dividend list after six years. It reflects the success of our turnaround and growth plans, which commenced in 2018, as well as our confidence in the Group’s future prospects.

We are now in the second year of our £20-£25 million capital investment plan, which supports our growth ambitions and will help to drive further operational improvements and margin gains.

Trading to date in the second half, traditionally our stronger period, is in line with expectations, and we believe that despite economic headwinds, the Group is well-placed to meet its targets for the financial year.”

An ‘Ugly’ delivery?

A couple of weeks ago the company was featured in an article in The Sunday Times entitled ‘The driver, the logistics firm and the ‘espionage’ referring to certain of its employees attempting to gain certain trade information.

It received a claim from Tuffnell Parcels Express in relation to confidential competitor details being obtained by DX in the past. The group intends to defend its position robustly and will respond to the claim in due course.

Analyst Opinion – Target Prices in 50p to 57p range

Guy Hewett at the group’s NOMAD and Joint Broker finnCap, is very positive about its prospects, putting a 57p Target Price on the shares.

For the year to end June this year he is going for revenues to have increased to £465.1m (£428.2m), with adjusted pre-tax profits of £25.4m (£20.6m), earnings of 3.7p (2.8p) and looking to pay a 1.5p (nil) per share dividend.

For 2024 he sees £484.1m sales, £29.9m profits, 4.2p earnings and a 1.7p dividend.

Over at the other Joint Broker, Liberum Capital, their analyst Gerald Khoo rates the shares as a Buy with a 50p Target Price.

His estimates for 2023 are £473m sales, £26.7m profits, 3.4p earnings and a 1.5p dividend.

For the coming year he looks for £496m revenues, £32.5m pre-tax profits, with 3.8p earnings and a 1.7p dividend per share.

Conclusion – at least a 25% upside in 2023

The group has a growing pipeline of new business and is expanding its depot network, which in turn should drive productivity improvements and importantly build up its customer service.

As long as the Tufnells situation does not get too messy, I continue to consider that this group’s shares are significantly undervalued at the current 28p.

I would reckon that there is at least a 25% upside in 2023.

Tip update: Transense Technologies builds its cash pile

Transense Technologies (LON: TRT) is finally coming to the attention of investors and the share price is recovering. There appears to have been some scepticism previously. The cash generative abilities of the business are even more obvious than before and, importantly, the company is achieving broker forecasts. Transense Technologies does not require any more cash from shareholders because of the growing cash pile.
In the six months to December 2022, revenues improved from £1.2m to £1.64m and the pre-tax profit jumped from £80,000 to £260,000. Lower corporate overheads helped to offset higher ...

Aquis weekly movers: Marula Mining increases Kinusi stake

Marula Mining (LON: MARU) has increased its stake in the Kinusi copper project in Tanzania from 49% to 75% for up to $550.000. The initial payment is $150,000 in cash and shares. There is high-grade copper mineralisation at the project.   

Trading in Pioneer Media Holdings Inc (LON: PNER) will end on the Aquis Stock Exchange on 9 March, but the share price recovered this week, having fallen by two-fifths to 7.5p during the previous week. Trading will continue on the NEO Exchange in Canada.

Shore has upgraded its forecasts for Arbuthnot Banking Group (LON: ARBB) with 2022 earnings increased by 11%. This reflects the benefits of higher interest rates with deposit rates lagging base rates. The 2022 pre-tax profit forecast is £29.5m and the 2023 forecast has been increased £28.5m to £40m. Estimated tangible NAV is 1194p a share.

Guanajuato Silver Company Ltd (LON: GSVR) announced drilling results from the San Ignacio mine. There are some high-grade silver intersections plus gold. A new area of thick mineralisation may have been found. This should lead to a significant increase in resources.  

==========

Fallers

Samarkand (LON: SMK) has benefitted from the easing of Covid restrictions in China. Although there was a short-term rise in infections, consumer confidence is improving since Chinese New Year. The Chinese government is keen to boost consumption. Partner brands using the company’s Nomad software platform are planning for growth this year and more premium beauty brands have been added to the platform. Samarkand could be profitable in the next financial year. The share price still fell 16.7% to 37.5p.

Invinity Energy Systems (LON: IES) raised £21.5m at 32p a share with up for £4m more to come from a two-for-19 open offer. Taiwan-based Everbrite Technology is investing £2.5m in the placing. The cash will be used for working capital, which is expected to last until the middle of 2024. At that time the next generation Mistral grid scale vanadium battery will be ready for launch. The company will not need to draw down the $10m convertible loan facility. The share price dipped 15.6% to 32.5p.

National Milk Records (LON: NMRP) increased interim revenues by 5% to £12m, while pre-tax profit improved from £750,000 to £790,000. A tax credit meant that earnings increased by a higher percentage. Net debt is £900,000. The main growth was in the core milk testing services, although genomics revenues rose from £173,000 to £336,000. Price increases will help margins in the second half. Full year pre-tax profit is expected to decline from £2.4m to £1.9m. Managing director Andy Warne is taking leave due to illness and the finance director is assuming operational control.

There are problems with the acquisition of a 19.8% stake in skincare products supplier Lush by Silverwood Brands (LON: SLWD) because Lush is refusing to register the change of ownership of the shares. Silverwood Brands is paying £216.8m for the stake and no reason was given for the refusal to record the transfer of the shares.  

TruSpine Technologies (LON: TSP) still hopes to receive the proposed bridge loan facility and share subscription by 1 March.

Telecoms services provider Global Connectivity (LON: GCON) is seeking further technology opportunities following the dilution of its stake in Rural Broadband Solutions to 15%. Any investment will be in a different area of the communications sector.

AIM weekly movers: Destiny Pharma secures partner but discounted placing hits share price

10

Trading recommenced in Caribbean-based oil and gas explorer Star Phoenix (LON: STA) shares following the appointment of a new auditor and publication of its annual report. The share price jumped 438% to 2.15p making the biggest riser on the week.

Mark Tindall increased his stake in Zinnwald Lithium (LON: ZNWD) from 3.17% to 4.01%. The share price is 26.4% ahead at 9.85p.

Construction recruitment and services provider Hercules Site Services (LON: HERC) shares went ex-dividend last week, but they still rose by 22% to 72p. They have been on the rise since reporting full year figures and the final dividend of 1.12p a share.  This is a new high for the shares.

Conroy Gold & Natural Resources (LON: CGNR) made a high-grade gold discovery in a new area of the Longford-Down Massif. Visible gold is present. The grades are between 12.8g/t and 123g/t at the Mines Royal option area in Northern Ireland. Exploration is being carried out with joint venture partner Demir Export. The share price is 21.7% higher at 21p.

==========

Fallers

Asia-focused investment company Jade Road Investments (LON: JADE) completed its fundraising which raised $1.75m gross, or $1.57m after underwriting costs, at 0.75p a share. The share price slumped 44.4% to 1.25p. This is a new low. Jade Road Investments issued nearly 202 million shares, nearly two-fifths of the enlarged share capital, and 171.2 million went to the underwriter.

Antibiotics developer Destiny Pharma (LON: DEST) is raising up to £8m at 35p a share via a placing (£7m) and open offer (up to £1m). The share price slumped 35.3% to 35.25p on the week, which could hamper the take-up of the open offer. The fundraising followed news that Sebela Pharmaceuticals has been secured as development and commercial partner for M3, which is focused on the prevention of C.dif recurrence. This de-risks the phase III trial, which Sebela will pay for in return for North American rights. Destiny Pharma retains the majority interests in the other rights.

The phase III trial will start next year and there could be a commercial launch in 2027 if everything goes to plan. There is an upfront payment of $1m and could be development and sales-based milestone payments of up to $570m. The royalty will be in double digits. There will be enough cash to get to the phase III trial and for further development of XF-73, which prevents post-surgical infections.  

Snowfall has hit production at the Pakrut gold mine operated by China Nonferrous Gold (LON: CNG) and the share price fell 28.3% to a new low of 2.15p. The Tajikistan mine has been hit by avalanches and landslides that have damaged power supply. Operations will be suspended for at least one month.  

Corporate finance adviser Marechale Capital (LON: MAC) has made a gain on its stake in biogas plants developer and operator Future Biogas Group after it was acquired by 3i Infrastructure (LON: 3IN). The shares were acquired in 2010-11 for £11,600 after Marechale Capital provided advice. The total amount received was £218,000. However, this is below book value.

CVS Group like-for-like growth at top of target range

0

Vet practices owner CVS Group (LON: CVSG) grew its like-for-like interim revenues by 7.5%, which is near to the top of the target range, and the pace of acquisitions has increased. Margins also increased.

The vet practices remain the main generator of revenues, with the rest coming from laboratories, crematoria and online retail. Healthy Pet Club membership increased by 4% to 481,000. Five practices were acquired in the first half and a further three since then. So far, this year £35.3m has been spent with up to £50m planned for each year.

In the six months to December 2022, revenues increased from £273.7m to £296.3m, while underlying pre-tax profit improved from £36.2m to £41.1m. All four divisions grew their revenues, although the crematoria profit was lower due to higher energy costs.

As well as acquisitions, CVS Group is upping the spending on capital investment. Some of that is going into a new greenfield vet practice and a new hospital in Bristol, but it is mainly on equipment for existing practices.

Net debt was £57.6m at the end of 2022. The new £350m bank facility leaves plenty of cash to fund other acquisitions, which may not all be in the UK.

Forecast

Peel Hunt forecasts that full year pre-tax profit will improve from £75.2m to £82.6m. Next year, it could reach £86.7m. This would generate enough cash for capital investment and still reduce net debt. However, acquisitions are likely to increase borrowings.

At 1898p, the shares are trading on 21 times prospective earnings. The dividend could be increased from 7p a share to 7.5p a share.

FTSE 100 dips as US economic strength ignites interest rate concerns

The FTSE 100 reflected the broad indecision in markets on Friday in a choppy session that saw early gains disappear, but losses held within a FTSE 100 range beginning to form around 8,020-7,850.

The FTSE 100 was trading at 7,882 at the time of writing.

Concerns around interest rates have prevented global equities breaking to the upside, but underlying strength in economies has provided support for stocks.

Better than expected UK consumer confidence data released on Friday was the latest data point to buoy markets.

“The UK economy recently narrowly avoided recession and the narrative has shifted to one of peak inflation, and an end in sight to interest rate hikes. Consumers with more confidence tend to be more willing to part with cash, which could feed through to better-than-expected retail performance,” said Sophie Lund-Yates, lead equity analyst at Hargreaves Lansdown

However, later in the session, US personal consumption data highlighted the current ‘good news is bad news’ nature of economic data. A much better than expected growth of 1.8% vs 1.3% for US personal spending in January sent equities into a tail spin as investors braced for higher interest rates for longer.

IAG

IAG demonstrated consumer’s greater propensity to spend with a strong recovery in 2022 revenues. IAG revenue rose to €23bn in 2022 – a substantial improvement on 2021’s meagre €8.3bn.

However, IAG shares dipped slightly on Friday as the airliner also revealed staggering net debt that has hardly moved since the end of 2021.

Tekcapital’s Guident to enhance autonomous vehicle safety with low-orbit satellites

Tekcapital’s Guident has once more demonstrated their prowess in autonomous vehicle safety technology with the inking of an agreement with NOVELSAT to bolster the connectivity of their remote monitoring systems.

NOVELSAT will provide Guident with access to low-earth space satellites that will facilitate always-on connectivity between autonomous vehicles and Guident’s remote safety centres. 

“NOVELSAT is excited to partner with Guident to bring the highest level of safety to autonomous systems,” said Gary Drutin, CEO of NOVELSAT.

“Our space-based connectivity solutions will ensure the always-on, high-capacity connectivity that is essential for the safe deployment and operation of autonomous vehicles and devices in diverse environments. We believe that this partnership will enable us to lead the way in providing innovative connectivity solutions that meet the needs of the autonomous systems industry.”

Guident’s autonomous vehicle safety technology

Guident’s technology is at the forefront of the autonomous vehicle safety requirement to have access to human intervention.

Tekcapital’s portfolio company has already validated their technology on numerous occasions by securing contracts with the Boca Raton technology campus, and very recently, Auve Technology.

Guident’s partnerships have made autonomous shuttles in closed circuits a reality by providing the necessary remote monitoring networks.

Today’s announced partnership with Novelsat will further strengthen Guident’s offering and possibly open the door to further deals in the future.

“Leveraging cross-network connectivity, our human-in-the-loop AI technologies will enable always-on remote monitoring control of autonomous vehicles and devices, thereby resolving unforeseen situations and providing unparalleled safety and reliability in various applications,” said Harald Braun, Chairman and CEO of Guident.

“We believe the integration of these technologies is a game-changer, and we are excited to be at the forefront by providing low earth orbit satellite monitoring redundance in addition to 5G and GPS monitoring of autonomous vehicles.”

Tekcapital portfolio

With a number of Tekcapital’s portfolio companies already listed in the case of Lucyd and Belluscura, Guident may prove to be something of future blockbuster as it subtly establishes a significant footprint in the autonomous vehicle safety market.

Autonomous vehicle safety is a fast moving industry and Guident has again proved it is one step ahead of competitors.

Tekcapital shares were trading positively at the time of writing.